OTC Markets OTCPK - Delayed Quote • USD Novonesis A/S (NVZMF) Follow Compare 55.20 -3.28 (-5.61%) At close: December 26 at 7:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8% Following increasing demand in the first nine months of the 2024 financial year, Novonesis delivers 9% organic sales growth with a strong 11% organic sales growth in the third quarter. The strong performance has led Novonesis to now expect full-year organic sales growth to be at the upper end of the 7-8% range, and the adjusted EBITDA margin is confirmed to be between 35.5-36.5%. COPENHAGEN, Denmark – November 7, 2024. Novonesis delivers 9% organic sales growth, in the first nine months of the 2 Trading statement 9M 2024 Organic pro forma sales growth of 9%, including 11% in the third quarter. Full-year organic sales growth outlook now expected at the upper end of the 7-8% range and the adjusted EBITDA margin confirmed between 35.5-36.5%. Ester Baiget, President & CEO: “We continue to execute strongly across the business. Supportive, broad-based demand coupled with strong innovation and commercial focus drive higher market penetration. Novonesis’ biosolutions are increasingly requested by customers to make their AXTA vs. NVZMY: Which Stock Is the Better Value Option? AXTA vs. NVZMY: Which Stock Is the Better Value Option? Is MAG Silver (MAG) Stock Outpacing Its Basic Materials Peers This Year? Here is how MAG Silver (MAG) and Novozymes A/S (NVZMY) have performed compared to their sector so far this year. Here's Why Momentum in Novozymes (NVZMY) Should Keep going If you are looking for stocks that are well positioned to maintain their recent uptrend, Novozymes (NVZMY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen. AXTA vs. NVZMY: Which Stock Should Value Investors Buy Now? AXTA vs. NVZMY: Which Stock Is the Better Value Option? Is Carpenter Technology (CRS) Stock Outpacing Its Basic Materials Peers This Year? Here is how Carpenter Technology (CRS) and Novozymes A/S (NVZMY) have performed compared to their sector so far this year. Here's What Could Help Novozymes (NVZMY) Maintain Its Recent Price Strength Novozymes (NVZMY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen. FUL or NVZMY: Which Is the Better Value Stock Right Now? FUL vs. NVZMY: Which Stock Is the Better Value Option? Is Novozymes (NVZMY) Stock Outpacing Its Basic Materials Peers This Year? Here is how Novozymes A/S (NVZMY) and Vizsla Silver Corp. (VZLA) have performed compared to their sector so far this year. ASH vs. NVZMY: Which Stock Should Value Investors Buy Now? ASH vs. NVZMY: Which Stock Is the Better Value Option? ASH or NVZMY: Which Is the Better Value Stock Right Now? ASH vs. NVZMY: Which Stock Is the Better Value Option? ASH vs. NVZMY: Which Stock Is the Better Value Option? ASH vs. NVZMY: Which Stock Is the Better Value Option? Novonesis AS's Dividend Analysis As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Novonesis AS's dividend performance and assess its sustainability. MATV vs. NVZMY: Which Stock Should Value Investors Buy Now? MATV vs. NVZMY: Which Stock Is the Better Value Option? Is CalMaine Foods (CALM) Stock Outpacing Its Basic Materials Peers This Year? Here is how Cal-Maine Foods (CALM) and Novozymes A/S (NVZMY) have performed compared to their sector so far this year. MATV or NVZMY: Which Is the Better Value Stock Right Now? MATV vs. NVZMY: Which Stock Is the Better Value Option? Are Basic Materials Stocks Lagging Novozymes (NVZMY) This Year? Here is how Novozymes A/S (NVZMY) and Paladin Energy (PALAF) have performed compared to their sector so far this year. MATV vs. NVZMY: Which Stock Is the Better Value Option? MATV vs. NVZMY: Which Stock Is the Better Value Option? Resolutions from the Extraordinary Shareholders’ Meeting 2024 Company Announcement no. 10 March 4, 2024Today an extraordinary shareholders’ meeting was conducted. The following resolutions were made: Adoption of Novonesis A/S as secondary name and amendment of the Articles of Association in accordance herewithElection of Jesper Brandgaard as Vice Chair of the Board of DirectorsElection of Lise Kaae, Kevin Lane and Kim Stratton as members of the Board of Directors Following the extraordinary shareholders’ meeting, the Board of Directors consists of the foll Performance Overview Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index Return NVZMF OMX Copenhagen 25 Index YTD +1.34% -1.32% 1-Year +7.85% -0.37% 3-Year -26.19% -6.88%